• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物膜的形成可保护沙门氏菌免受环丙沙星在慢性携带小鼠模型中的体内和体外的抗生素作用

Biofilm Formation Protects Salmonella from the Antibiotic Ciprofloxacin In Vitro and In Vivo in the Mouse Model of chronic Carriage.

机构信息

Department of Microbial Infection and Immunity, Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, USA.

School of Mathematics and Natural Sciences, University of Rio Grande, P.O. Box 500, Rio Grande, OH, USA.

出版信息

Sci Rep. 2018 Jan 9;8(1):222. doi: 10.1038/s41598-017-18516-2.

DOI:10.1038/s41598-017-18516-2
PMID:29317704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5760579/
Abstract

Typhoid fever is caused by the human-restricted pathogen Salmonella enterica sv. Typhi. Approximately 5% of people that resolve the disease become chronic carriers, with the gallbladder as the main reservoir of the bacteria. Of these, about 90% present with gallstones, on which Salmonella form biofilms. Because S. Typhi is a human-restricted pathogen, these carriers are the main source of dissemination of the disease; unfortunately, antibiotic treatment has shown to be an ineffective therapy. This is believed to be caused by the inherent antibiotic resistance conferred by Salmonella biofilms growing on gallstones. The gallstone mouse model with S. Typhimurium has proven to be an excellent surrogate for S. Typhi chronic infection. In this study, we test the hypothesis that the biofilm state confers Salmonella with the increased resistance to antibiotics observed in cases of chronic carriage. We found that, in the biofilm state, Salmonella is significantly more resistant to ciprofloxacin, a common antibiotic used for the treatment of Salmonella, both in vitro (p < 0.001 for both S. Typhi and S. Typhimurium with respect to planktonic cells) and in vivo (p = 0.0035 with respect to control mice).

摘要

伤寒是由人类局限性病原体沙门氏菌肠炎亚种 Typhi 引起的。大约 5%的患者在治愈后成为慢性携带者,而胆囊是细菌的主要储存库。其中,约 90%的人患有胆结石,沙门氏菌在这些胆结石上形成生物膜。由于 S. Typhi 是一种人类局限性病原体,这些携带者是疾病传播的主要来源;不幸的是,抗生素治疗已被证明是一种无效的疗法。这被认为是由于生长在胆结石上的沙门氏菌生物膜赋予的固有抗生素耐药性所致。鼠胆结石携带鼠伤寒沙门氏菌模型已被证明是沙门氏菌慢性感染的理想替代模型。在这项研究中,我们检验了这样一个假设,即生物膜状态赋予沙门氏菌对慢性携带中观察到的抗生素耐药性增加。我们发现,在生物膜状态下,沙门氏菌对环丙沙星的耐药性明显增强,环丙沙星是一种用于治疗沙门氏菌的常用抗生素,无论是在体外(p<0.001,分别针对浮游细胞的 S. Typhi 和 S. Typhimurium)还是在体内(p=0.0035,与对照小鼠相比)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f35/5760579/98949aab9acd/41598_2017_18516_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f35/5760579/ce6af6d62e9a/41598_2017_18516_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f35/5760579/9933e4657a76/41598_2017_18516_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f35/5760579/98949aab9acd/41598_2017_18516_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f35/5760579/ce6af6d62e9a/41598_2017_18516_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f35/5760579/9933e4657a76/41598_2017_18516_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f35/5760579/98949aab9acd/41598_2017_18516_Fig3_HTML.jpg

相似文献

1
Biofilm Formation Protects Salmonella from the Antibiotic Ciprofloxacin In Vitro and In Vivo in the Mouse Model of chronic Carriage.生物膜的形成可保护沙门氏菌免受环丙沙星在慢性携带小鼠模型中的体内和体外的抗生素作用
Sci Rep. 2018 Jan 9;8(1):222. doi: 10.1038/s41598-017-18516-2.
2
Development of small molecules that work cooperatively with ciprofloxacin to clear salmonella biofilms in a chronic gallbladder carriage model.开发在慢性胆囊携带模型中与环丙沙星协同作用以清除沙门氏菌生物膜的小分子。
Eur J Med Chem. 2022 Mar 15;232:114203. doi: 10.1016/j.ejmech.2022.114203. Epub 2022 Feb 19.
3
Pathoadaptive Alteration of Biofilm Formation in Response to the Gallbladder Environment.生物膜形成的病理适应改变以响应胆囊环境。
J Bacteriol. 2019 Jun 21;201(14). doi: 10.1128/JB.00774-18. Print 2019 Jul 15.
4
A dual-therapy approach for the treatment of biofilm-mediated Salmonella gallbladder carriage.一种治疗生物膜介导的沙门氏菌胆囊携带的双重疗法。
PLoS Pathog. 2020 Dec 28;16(12):e1009192. doi: 10.1371/journal.ppat.1009192. eCollection 2020 Dec.
5
The Abundance and Organization of Extracellular Polymeric Substances in Gallbladder-Mimicking Environments and .胆囊模拟环境中细胞外聚合物质的丰度和组织。
Infect Immun. 2021 Oct 15;89(11):e0031021. doi: 10.1128/IAI.00310-21. Epub 2021 Aug 16.
6
Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.喹诺酮耐药性获得对肠炎沙门氏菌生物膜形成及适应性的影响。
J Antimicrob Chemother. 2014 Jul;69(7):1815-24. doi: 10.1093/jac/dku078. Epub 2014 Apr 4.
7
Establishment of Chronic Typhoid Infection in a Mouse Carriage Model Involves a Type 2 Immune Shift and T and B Cell Recruitment to the Gallbladder.在小鼠携带模型中建立慢性伤寒感染涉及 2 型免疫转移以及 T 和 B 细胞向胆囊募集。
mBio. 2019 Oct 1;10(5):e02262-19. doi: 10.1128/mBio.02262-19.
8
Human Bile-Mediated Regulation of Curli Fimbriae.人胆汁对卷曲菌毛的调节作用
J Bacteriol. 2019 Aug 22;201(18). doi: 10.1128/JB.00055-19. Print 2019 Sep 15.
9
Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage.胆石在沙门氏菌属胆囊定植和携带中起重要作用。
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4353-8. doi: 10.1073/pnas.1000862107. Epub 2010 Feb 22.
10
In vitro effect of subinhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium isolated in Slovakia.亚抑菌浓度抗生素对斯洛伐克分离的肠炎沙门氏菌鼠伤寒血清型临床菌株生物膜形成的体外影响。
J Appl Microbiol. 2008 May;104(5):1294-301. doi: 10.1111/j.1365-2672.2007.03653.x. Epub 2007 Nov 20.

引用本文的文献

1
The molecular mechanisms of quinolone resistance in Salmonella: a review.沙门氏菌中喹诺酮耐药性的分子机制:综述
Arch Microbiol. 2025 Aug 19;207(9):230. doi: 10.1007/s00203-025-04430-z.
2
Antimicrobial resistance and biofilm formation in rarely reported serovars from patients presenting with gastroenteritis in Nairobi, Kenya.肯尼亚内罗毕肠胃炎患者中罕见血清型的抗菌药物耐药性及生物膜形成情况
Front Microbiol. 2025 Jun 25;16:1628784. doi: 10.3389/fmicb.2025.1628784. eCollection 2025.
3
Salmonella stress response systems as targets for anti-virulence strategies.

本文引用的文献

1
New Technologies for Studying Biofilms.生物膜研究的新技术。
Microbiol Spectr. 2015 Aug;3(4). doi: 10.1128/microbiolspec.MB-0016-2014.
2
Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.侵袭性沙门氏菌感染的流行病学、临床表现、实验室诊断、抗菌药物耐药性及抗菌药物管理
Clin Microbiol Rev. 2015 Oct;28(4):901-37. doi: 10.1128/CMR.00002-15.
3
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.
沙门氏菌应激反应系统作为抗毒力策略的靶点。
BMC Microbiol. 2025 Jul 2;25(1):378. doi: 10.1186/s12866-025-04003-6.
4
Defense mechanisms of against antibiotics: a review.细菌对抗生素的防御机制:综述
Front Antibiot. 2024 Sep 17;3:1448796. doi: 10.3389/frabi.2024.1448796. eCollection 2024.
5
Functional role of the biofilm regulator CsgD in sv. Typhi.生物膜调节因子CsgD在伤寒沙门氏菌中的功能作用。
Front Cell Infect Microbiol. 2024 Dec 11;14:1478488. doi: 10.3389/fcimb.2024.1478488. eCollection 2024.
6
Biofilm Production and Antibiogram Profiles in and Salmonella.生物膜产生及在[具体内容缺失]和沙门氏菌中的药敏谱
Indian J Microbiol. 2024 Dec;64(4):1512-1517. doi: 10.1007/s12088-023-01149-7. Epub 2023 Dec 9.
7
Typhi Haplotype 58 biofilm formation and genetic variation in isolates from typhoid fever patients with gallstones in an endemic setting in Kenya.肯尼亚流行地区有胆石症的伤寒患者分离株中 Typhi Haplotype 58 的生物膜形成和遗传变异。
Front Cell Infect Microbiol. 2024 Nov 13;14:1468866. doi: 10.3389/fcimb.2024.1468866. eCollection 2024.
8
Antibiotic-recalcitrant Salmonella during infection.感染期间对抗生素耐药的沙门氏菌。
Nat Rev Microbiol. 2025 May;23(5):276-287. doi: 10.1038/s41579-024-01124-z. Epub 2024 Nov 18.
9
Fecal Shedding, Antimicrobial Resistance and Biofilm formation on Simulated Gallstones by Typhi Isolated from Typhoid Cases and Asymptomatic Carriers in Nairobi, Kenya.从肯尼亚内罗毕伤寒病例和无症状携带者中分离出的伤寒杆菌在模拟胆结石上的粪便排出、耐药性及生物膜形成
Int J Clin Microbiol. 2024;1(2):23-36. doi: 10.14302/issn.2690-4721.ijcm-24-5030. Epub 2024 Apr 24.
10
Typhi Haplotype 58 (H58) Biofilm Formation and Genetic Variation in Typhoid Fever Patients with Gallstones in an Endemic Setting in Kenya.肯尼亚地方病流行区伤寒热合并胆结石患者中伤寒杆菌单倍型58(H58)的生物膜形成及基因变异
medRxiv. 2024 Jun 4:2024.06.03.24308409. doi: 10.1101/2024.06.03.24308409.
伤寒沙门氏菌主要多重耐药H58分支的系统发育地理学分析确定了洲际和洲内传播事件。
Nat Genet. 2015 Jun;47(6):632-9. doi: 10.1038/ng.3281. Epub 2015 May 11.
4
Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence.沙门氏菌慢性携带:流行病学、诊断及胆囊持续感染情况
Trends Microbiol. 2014 Nov;22(11):648-55. doi: 10.1016/j.tim.2014.06.007. Epub 2014 Jul 22.
5
Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment.盲肠淋巴结树突状细胞中存在生长缓慢的细菌,其表型对抗生素治疗具有耐受性。
PLoS Biol. 2014 Feb 18;12(2):e1001793. doi: 10.1371/journal.pbio.1001793. eCollection 2014 Feb.
6
Identification of Salmonella enterica serovar Typhimurium genes regulated during biofilm formation on cholesterol gallstone surfaces.鉴定鼠伤寒沙门氏菌血清型在胆固醇胆石表面生物膜形成过程中受调控的基因。
Infect Immun. 2013 Oct;81(10):3770-80. doi: 10.1128/IAI.00647-13. Epub 2013 Jul 29.
7
Gallbladder epithelium as a niche for chronic Salmonella carriage.胆囊上皮作为慢性沙门氏菌携带的生态位。
Infect Immun. 2013 Aug;81(8):2920-30. doi: 10.1128/IAI.00258-13. Epub 2013 Jun 3.
8
In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.体外检测氟喹诺酮类药物对沙门氏菌活性的药敏试验:CLSI 标准的最新变化。
Clin Infect Dis. 2012 Oct;55(8):1107-13. doi: 10.1093/cid/cis600. Epub 2012 Jul 2.
9
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).用于治疗伤寒和副伤寒(肠热病)的氟喹诺酮类药物。
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004530. doi: 10.1002/14651858.CD004530.pub4.
10
Effect of biofilm formation on the excretion of Salmonella enterica serovar Typhi in feces.生物膜形成对伤寒沙门氏菌 Typhi 在粪便中排泄的影响。
Int J Infect Dis. 2011 Nov;15(11):e747-52. doi: 10.1016/j.ijid.2011.06.003. Epub 2011 Aug 3.